Choline C 11 Injection

Chemical NameCholine C 11 Injection
Dosage FormInjection (intravenous; 48 MBq to 1225 MBq (4 mCi to 33.1 mCi))
Drug ClassRadioactive diagnostic agents
SystemMale reproductive
CompanyMayo Clinic
Approval Year2012


  • Indicated for positron emission tomography (PET) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging
Last updated on 4/25/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Choline C 11 Injection Prescribing Information.2012Mayo Clinic PET Radiochemistry Facility, Rochester, MN
Document TitleYearSource
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. 2022European Association of Urology
Optimum imaging strategies for advanced prostate Cancer: ASCO guideline.2020American Society of Clinical Oncology